MS4A1 and cancer: Importantly, both MS4A1 and TIL-B levels are consistently prognostic across five cancer types, namely HNSCC, LUAD, CESC, LGG, and KIRP, with distinct Be2 and BK signatures (especially for IL2, IL6, and PD-L2 expressions).